EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

Biocan Novel R

Homepage Products Veterinary products Biocan Novel R

* NOVELTY 2017 * Monovalent rabies vaccine containing time-tested strain SAD Vnukovo - 32

type of preparative: Vaccines
target species animals: Dog

Can we help you?

Composition:

Liquid fraction (inactivated):
Inactivated rabies virus, strain SAD Vnukovo-32    ? 2.0 IU***

Adjuvant:
Aluminium hydroxide gel 1.8–2.2 mg

Indication:

Active immunization of dogs from 12 weeks of age to prevent mortality, clinical signs and infection caused by rabies virus.
In case of need, dogs younger than 12 weeks can be vaccinated. In this case the vaccine can be administered from 6 weeks of age in two doses. The second dose should not be administered before 12 weeks of age and not earlier than 3 weeks after the first dose.

Onset of immunity:
2 weeks after a single vaccination from 12 weeks of age.

Duration of immunity:
At least three years following the primary vaccination course. Duration of immunity was demonstrated after one vaccination at 12 weeks of age.

Dosage:

1 ml subcutaneously. Do not use chemically sterilised syringes or needles, as these may interfere with the effectiveness of the vaccine. Shake well before administration.

Basic vaccination scheme:
One dose of Biocan Novel R from 12 weeks of age.
The efficacy is proven after a single dose from 12 weeks of age in laboratory studies.
However, in field studies 10% of seronegative dogs did not show seroconversion (> 0.1 IU/ml)
3–4 weeks after single primary vaccination against rabies. Another 17% did not show the 0.5 IU/ml rabies antibody titre required by some non-EU countries to travel in. In case of travelling to risk areas or for travel outside the EU veterinary surgeons may wish to use a two dose primary course including rabies or give an additional rabies vaccination after 12 weeks.
In case of need, dogs younger than 12 weeks can be vaccinated. In this case the vaccine can be administered from 6 weeks of age in two doses. The second dose should not be administered before 12 weeks of age and not earlier than 3 weeks after the first dose.

Revaccination scheme:
A single dose of Biocan Novel R should be given every 3 years.

Shelf life:

24 months, after reconstitution according to directions: administer the vaccine immediately.

Special storage precaution:

Store and transport refrigerated (2 °C – 8 °C). Do not freeze.

Package:

10 × 1 dose, 25 × 1 dose


Contact us


antispam
Please fill in the text displayed in the picture

or call


+420 517 318 598